Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.80 billion. The enterprise value is $2.19 billion.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 105.58 million shares outstanding. The number of shares has increased by 10.78% in one year.
| Current Share Class | 105.58M |
| Shares Outstanding | 105.58M |
| Shares Change (YoY) | +10.78% |
| Shares Change (QoQ) | +16.34% |
| Owned by Insiders (%) | 4.12% |
| Owned by Institutions (%) | 91.24% |
| Float | 93.47M |
Valuation Ratios
The trailing PE ratio is 26.68 and the forward PE ratio is 19.68.
| PE Ratio | 26.68 |
| Forward PE | 19.68 |
| PS Ratio | 0.82 |
| Forward PS | 1.13 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | 15.63 |
| P/OCF Ratio | 10.25 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 47.41, with an EV/FCF ratio of 19.06.
| EV / Earnings | 33.66 |
| EV / Sales | 1.00 |
| EV / EBITDA | 47.41 |
| EV / EBIT | 2,091.41 |
| EV / FCF | 19.06 |
Financial Position
The company has a current ratio of 4.63, with a Debt / Equity ratio of 0.70.
| Current Ratio | 4.63 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 5.15 |
| Debt / FCF | 9.11 |
| Interest Coverage | 0.02 |
Financial Efficiency
Return on equity (ROE) is 4.91% and return on invested capital (ROIC) is 0.07%.
| Return on Equity (ROE) | 4.91% |
| Return on Assets (ROA) | 0.02% |
| Return on Invested Capital (ROIC) | 0.07% |
| Return on Capital Employed (ROCE) | 0.04% |
| Weighted Average Cost of Capital (WACC) | 5.11% |
| Revenue Per Employee | $2.62M |
| Profits Per Employee | $77,913 |
| Employee Count | 835 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 2.39 |
Taxes
| Income Tax | -40.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.31% in the last 52 weeks. The beta is 0.25, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -53.31% |
| 50-Day Moving Average | 20.10 |
| 200-Day Moving Average | 19.98 |
| Relative Strength Index (RSI) | 31.46 |
| Average Volume (20 Days) | 3,153,112 |
Short Selling Information
The latest short interest is 24.92 million, so 23.60% of the outstanding shares have been sold short.
| Short Interest | 24.92M |
| Short Previous Month | 25.33M |
| Short % of Shares Out | 23.60% |
| Short % of Float | 26.66% |
| Short Ratio (days to cover) | 10.11 |
Income Statement
In the last 12 months, SRPT had revenue of $2.18 billion and earned $65.06 million in profits. Earnings per share was $0.64.
| Revenue | 2.18B |
| Gross Profit | -141.65M |
| Operating Income | 1.05M |
| Pretax Income | 24.47M |
| Net Income | 65.06M |
| EBITDA | 46.18M |
| EBIT | 1.05M |
| Earnings Per Share (EPS) | $0.64 |
Full Income StatementBalance Sheet
The company has $653.19 million in cash and $1.05 billion in debt, with a net cash position of -$393.86 million or -$3.73 per share.
| Cash & Cash Equivalents | 653.19M |
| Total Debt | 1.05B |
| Net Cash | -393.86M |
| Net Cash Per Share | -$3.73 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 14.26 |
| Working Capital | 1.81B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $175.28 million and capital expenditures -$60.40 million, giving a free cash flow of $114.87 million.
| Operating Cash Flow | 175.28M |
| Capital Expenditures | -60.40M |
| Depreciation & Amortization | 45.14M |
| Net Borrowing | -159.38M |
| Free Cash Flow | 114.87M |
| FCF Per Share | $1.09 |
Full Cash Flow StatementMargins
Gross margin is -6.49%, with operating and profit margins of 0.05% and 2.98%.
| Gross Margin | -6.49% |
| Operating Margin | 0.05% |
| Pretax Margin | 1.12% |
| Profit Margin | 2.98% |
| EBITDA Margin | 2.11% |
| EBIT Margin | 0.05% |
| FCF Margin | 5.26% |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.78% |
| Shareholder Yield | -10.78% |
| Earnings Yield | 3.62% |
| FCF Yield | 6.40% |
Analyst Forecast
The average price target for SRPT is $22.00, which is 29.34% higher than the current price. The consensus rating is "Hold".
| Price Target | $22.00 |
| Price Target Difference | 29.34% |
| Analyst Consensus | Hold |
| Analyst Count | 24 |
| Revenue Growth Forecast (5Y) | -3.02% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
SRPT has an Altman Z-Score of 0.28 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.28 |
| Piotroski F-Score | 6 |
